SYSTEMIC MASTOCYTOSIS
Clinical trials for SYSTEMIC MASTOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC MASTOCYTOSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC MASTOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bone drug shows promise for rare mast cell disorder
Disease control CompletedThis study tested a drug called denosumab in 24 adults with bone loss (osteoporosis) caused by systemic mastocytosis, a rare disease where certain immune cells build up. Participants received either denosumab or a placebo every 6 months for 3 years. The goal was to see if denosum…
Matched conditions: SYSTEMIC MASTOCYTOSIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug flotetuzumab tested for tough blood cancers
Disease control CompletedThis early-stage trial tested the safety and best dose of flotetuzumab, a lab-made antibody, in 13 people with advanced blood cancers that had come back or stopped responding to treatment. The goal was to see if the drug could help control the disease by blocking cancer cell grow…
Matched conditions: SYSTEMIC MASTOCYTOSIS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 04, 2026 16:18 UTC